Company Filing History:
Years Active: 2012-2022
Title: Innovations of Ursula Bodendorf
Introduction
Ursula Bodendorf is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein expression. With a total of two patents to her name, her work has implications for drug discovery and production methods.
Latest Patents
Ursula's latest patents include "Vertebrate cells and methods for recombinantly expressing a polypeptide of interest." This invention pertains to isolated vertebrate cells that are altered to impair the function of the endogenous protease matriptase. These cells are designed to express and secrete a polypeptide of interest, significantly reducing the clipping of the polypeptide during production. Another important patent is related to "Kallikrein 7 modulators," which focuses on the crystal structure of the serine protease kallikrein 7. This invention aids in drug discovery by identifying compounds that specifically bind to the active site of kallikrein 7.
Career Highlights
Ursula Bodendorf is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to explore innovative solutions in the field of biotechnology.
Collaborations
Ursula has collaborated with notable colleagues such as Stefanie Flohr and Stefan Andreas Randl, contributing to a dynamic research environment.
Conclusion
Ursula Bodendorf's contributions to biotechnology through her patents and work at Novartis AG highlight her role as an influential inventor in the field. Her innovations continue to pave the way for advancements in drug discovery and recombinant protein production.